IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Venture Capital Investment in U.S. Biotech Hits 12-year Low

11:27 AM MDT | April 22, 2009 | Alex Scott

Venture capital investment in U.S. Biotech firms during the first quarter of the year fell 47%, compared with the year-ago period, to $3 billion, according to a report by PricewaterhouseCoopers (PWC) and the National Venture Capital Association (Boston, MA) based on data from Thomson Reuters. The investment in the sector in the U.S. is the lowest in 12 years, the authors say. The number of investment deals in the sector fell 37%, compared with the year-ago period, to 546.   The report’s authors cited uncertainty among entrepreneurs and venture...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa